HLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 EA Q1 2026 Earnings EPS Misses Estimates by 36 Shares Edge Lower BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress RYAM Q1 2026 Earnings Significant EPS Miss Amid Stock Resilience UTMD Q1 2024 Earnings Solid EPS Performance Amidst Cautious Market Reaction